{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:41:30Z","timestamp":1768070490814,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00345-016-1856-9","type":"journal-article","created":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T03:50:35Z","timestamp":1465444235000},"page":"237-243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette\u2013Gu\u00e9rin immunotherapy?"],"prefix":"10.1007","volume":"35","author":[{"given":"Thomasz","family":"Golabek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Palou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria","family":"Gaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Villavicencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"issue":"1","key":"1856_CR1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eururo.2007.06.030","volume":"53","author":"S Denzinger","year":"2008","unstructured":"Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M (2008) Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol 53(1):146\u2013152","journal-title":"Eur Urol"},{"issue":"4","key":"1856_CR2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","volume":"64","author":"M Babjuk","year":"2013","unstructured":"Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comp\u00e9rat E, Sylvester RJ, Kaasinen E, B\u00f6hle A, Redorta JP, Roupr\u00eat M (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64(4):639\u2013653","journal-title":"Eur Urol"},{"issue":"1","key":"1856_CR3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","volume":"169","author":"O Shahin","year":"2003","unstructured":"Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE (2003) A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette\u2013Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169(1):96\u2013100","journal-title":"J Urol"},{"issue":"2","key":"1856_CR4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000087162","volume":"75","author":"B G\u00fcnl\u00fcsoy","year":"2005","unstructured":"G\u00fcnl\u00fcsoy B, De\u011firmenci T, Arslan M, Nergiz N, Minareci S, Ayder AR (2005) Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette\u2013Gu\u00e9rin. Urol Int 75(2):107\u2013113","journal-title":"Urol Int"},{"issue":"9 Pt B","key":"1856_CR5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1464-410X.2008.07969.x","volume":"102","author":"P Emiliozzi","year":"2008","unstructured":"Emiliozzi P, Pansadoro A, Pansadoro V (2008) The optimal management of T1G3 bladder cancer. BJU Int. 102(9 Pt B):1265\u20131273","journal-title":"BJU Int."},{"key":"1856_CR6","unstructured":"Gospodarowicz MK (2002) Urological tumours: bladder. In: Sobin LH, Wittekind Ch (eds) TNM classification of malignant tumours, 6th edn. International Union against Cancer. Wiley-Liss, New York"},{"key":"1856_CR7","unstructured":"Mostofi FK, Sobin LH, Torloni H (1973) Histological typing of urinary bladder tumors. In: International classification of tumors no 10. WHO, Geneve"},{"key":"1856_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"TM Therneau","year":"1994","unstructured":"Therneau TM, Grambsch PM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515\u2013526","journal-title":"Biometrika"},{"issue":"1","key":"1856_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000019664","volume":"34","author":"T Lebret","year":"1998","unstructured":"Lebret T, Gaudez F, Herv\u00e9 JM, Barr\u00e9 P, Lugagne PM, Botto H (1998) Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success. Eur Urol 34(1):67\u201372","journal-title":"Eur Urol"},{"issue":"6","key":"1856_CR10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1464-410X.2002.02969.x","volume":"90","author":"JN Kulkarni","year":"2002","unstructured":"Kulkarni JN, Gupta R (2002) Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette\u2013Gu\u00e9rin (Danish 1331 strain). BJU Int 90(6):554\u2013557","journal-title":"BJU Int"},{"issue":"6","key":"1856_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0302-2838(02)00173-2","volume":"41","author":"JJ Patard","year":"2002","unstructured":"Patard JJ, Rodriguez A, Leray E, Rioux-Leclercq N, Guill\u00e9 F, Lobel B (2002) Intravesical Bacillus Calmette\u2013Guerin treatment improves patient survival in T1G3 bladder tumours. Eur Urol 41(6):635\u2013641","journal-title":"Eur Urol"},{"issue":"2","key":"1856_CR12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/S1677-5538.IBJU.2014.02.06","volume":"40","author":"DJ Canter","year":"2014","unstructured":"Canter DJ, Revenig LM, Smith ZL, Dobbs RW, Malkowicz SB, Issa MM, Guzzo TJ (2014) Re-examination of the natural history of high-grade T1 bladder cancer using a large contemporary cohort. Int Braz J Urol Mar 40(2):172\u2013178","journal-title":"Int Braz J Urol Mar"},{"issue":"1","key":"1856_CR13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","volume":"158","author":"MS Cookson","year":"1997","unstructured":"Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR (1997) The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158(1):62\u201367","journal-title":"J Urol"},{"issue":"3","key":"1856_CR14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466\u2013477","journal-title":"Eur Urol"},{"issue":"5","key":"1856_CR15","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pi\u00f1eiro L, Gonzalez M, Portillo J, Ojea A, Pertusa C, Rodriguez-Molina J, Camacho JE, Rabadan M, Astobieta A, Montesinos M, Isorna S, Munta\u00f1ola P, Gimeno A, Blas M, Martinez-Pi\u00f1eiro JA (2009) Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette\u2013Guerin: the CUETO scoring model. J Urol 182(5):2195\u20132203","journal-title":"J Urol"},{"issue":"3","key":"1856_CR16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.eururo.2011.05.033","volume":"60","author":"J Fernandez-Gomez","year":"2011","unstructured":"Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Pi\u00f1eiro L, Ojea A, Portillo J, Montesinos M, Gonzalez M, Pertusa C, Rodriguez-Molina J, Camacho JE, Rabadan M, Astobieta A, Isorna S, Munta\u00f1ola P, Gimeno A, Blas M, Martinez-Pi\u00f1eiro JA, Club Urol\u00f3gico Espa\u00f1ol de Tratamiento Oncol\u00f3gico (2011) The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette\u2013Gu\u00e9rin: external validation of the EORTC risk tables. Eur Urol 60(3):423\u2013430","journal-title":"Eur Urol"},{"issue":"6","key":"1856_CR17","doi-asserted-by":"crossref","first-page":"e96849","DOI":"10.1371\/journal.pone.0096849","volume":"9","author":"MM Vedder","year":"2014","unstructured":"Vedder MM, M\u00e1rquez M, de Bekker-Grob EW, Calle ML, Dyrskj\u00f8t L, Kogevinas M, Segersten U, Malmstr\u00f6m PU, Algaba F, Beukers W, Orntoft TF, Zwarthoff E, Real FX, Malats N, Steyerberg EW (2014) Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours. PLoS One 9(6):e96849","journal-title":"PLoS One"},{"issue":"2","key":"1856_CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0090-4295(01)01603-X","volume":"59","author":"V Pansadoro","year":"2002","unstructured":"Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN (2002) Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette\u2013Gu\u00e9rin: 18-year experience. Urology 59(2):227\u2013231","journal-title":"Urology"},{"issue":"4","key":"1856_CR19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1464-410X.2010.09572.x","volume":"107","author":"DM Kakiashvili","year":"2011","unstructured":"Kakiashvili DM, van Rhijn BW, Trottier G, Jewett MA, Fleshner NE, Finelli A, Azuero J, Bangma CH, Vajpeyi R, Alkhateeb S, Hanna S, Kostynsky A, Kuk C, Van Der Kwast TH, Zlotta AR (2011) Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette\u2013Gu\u00e9rin treatment. BJU Int 107(4):540\u2013546","journal-title":"BJU Int"},{"issue":"4","key":"1856_CR20","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)65168-3","volume":"167","author":"S Holmang","year":"2002","unstructured":"Holmang S, Johansson SL (2002) Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 167(4):1634\u20131637","journal-title":"J Urol"},{"issue":"3","key":"1856_CR21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.eururo.2011.11.011","volume":"61","author":"S Holm\u00e4ng","year":"2012","unstructured":"Holm\u00e4ng S, Str\u00f6ck V (2012) Should follow-up cystoscopy in bacillus Calmette\u2013Gu\u00e9rin-treated patients continue after five tumour-free years? Eur Urol 61(3):503\u2013507","journal-title":"Eur Urol"},{"issue":"2","key":"1856_CR22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0090-4295(99)00116-8","volume":"54","author":"R Hurle","year":"1999","unstructured":"Hurle R, Losa A, Manzetti A, Lembo A (1999) Intravesical bacille Calmette\u2013Gu\u00e9rin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up. Urology 54(2):258\u2013263","journal-title":"Urology"},{"issue":"5","key":"1856_CR23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1464-410X.1997.00431.x","volume":"80","author":"HW Herr","year":"1997","unstructured":"Herr HW (1997) Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome. Br J Urol 80(5):762\u2013765","journal-title":"Br J Urol"},{"issue":"6","key":"1856_CR24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.urology.2009.09.088","volume":"75","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto K, Kikuchi E, Horiguchi Y, Tanaka N, Miyajima A, Nakagawa K, Nakashima J, Oya M (2010) Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods. Urology 75(6):1385\u20131390","journal-title":"Urology"},{"issue":"6","key":"1856_CR25","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.juro.2009.08.046","volume":"182","author":"BG Volkmer","year":"2009","unstructured":"Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE (2009) Upper urinary tract recurrence after radical cystectomy for bladder cancer\u2014who is at risk? J Urol 182(6):2632\u20132637","journal-title":"J Urol"},{"key":"1856_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1040-8428(03)00079-9","volume":"47","author":"Z Kirkali","year":"2003","unstructured":"Kirkali Z, Tuzel E (2003) Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47:155\u2013169","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"1856_CR27","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0022-5347(01)65570-8","volume":"156","author":"HW Herr","year":"1996","unstructured":"Herr HW, Cookson MS, Soloway SM (1996) Upper tract tumors in patients with primary bladder cancer followed for 15\u00a0years. J Urol 156(4):1286\u20131287","journal-title":"J Urol"},{"key":"1856_CR28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0090-4295(96)00571-7","volume":"49","author":"E Solsona","year":"1997","unstructured":"Solsona E, Iborra I, Ricos JV, Dumont R, Casanova JL, Calabuig C (1997) Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): Its impact on management. Urology 49:347\u2013352","journal-title":"Urology"},{"key":"1856_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-5347(17)42984-3","volume":"138","author":"MJA Torres De","year":"1987","unstructured":"De Torres MJA, Banus GJM, Palou RJ, Morote RJ (1987) Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma. J Urol 138:49\u201351","journal-title":"J Urol"},{"key":"1856_CR30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.1998.16.3.1099","volume":"16","author":"HW Herr","year":"1998","unstructured":"Herr HW (1998) Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 16:1099\u20131102","journal-title":"J Clin Oncol"},{"key":"1856_CR31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000474814","volume":"21","author":"J Palou","year":"1992","unstructured":"Palou J, Farina LA, Villavicencio H, Vicente J (1992) Upper tract urothelial tumor after transurethral resection for bladder tumor. Eur Urol 21:110\u2013114","journal-title":"Eur Urol"},{"issue":"1","key":"1856_CR32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","volume":"62","author":"G Lughezzani","year":"2012","unstructured":"Lughezzani G, Burger M, Margulis V, Matin SF, Novara G, Roupret M, Shariat SF, Wood CG, Zigeuner R (2012) Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol 62(1):100\u2013114","journal-title":"Eur Urol"},{"issue":"5","key":"1856_CR33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.eururo.2008.06.062","volume":"54","author":"HW Herr","year":"2008","unstructured":"Herr HW (2008) Is maintenance bacillus Calmette\u2013Gu\u00e9rin really necessary? Eur Urol 54(5):971\u2013973","journal-title":"Eur Urol"},{"issue":"2","key":"1856_CR34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","volume":"54","author":"M Babjuk","year":"2008","unstructured":"Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, B\u00f6hle A, Palou-Redorta J, European Association of Urology (EAU) (2008) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54(2):303\u2013314","journal-title":"Eur Urol"},{"issue":"5","key":"1856_CR35","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0022-5347(05)01002-5","volume":"175","author":"RT Divrik","year":"2006","unstructured":"Divrik RT, Yildirim U, Zorlu F, Ozen H (2006) The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 175(5):1641\u20131644","journal-title":"J Urol"},{"issue":"5","key":"1856_CR36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.eururo.2003.12.016","volume":"45","author":"G Jakse","year":"2004","unstructured":"Jakse G, Algaba F, Malmstr\u00f6m PU, Oosterlinck WA (2004) Second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 45(5):539\u2013546","journal-title":"Eur Urol"},{"key":"1856_CR37","doi-asserted-by":"crossref","first-page":"e1001","DOI":"10.1016\/S1569-9056(14)60984-2","volume":"13","author":"P Gontero","year":"2014","unstructured":"Gontero P, Sylvester R, Pisano F et al (2014) The impact of re-TUR on clinical outcomes in a large cohort of t1g3 patients treated with BCG. Eur Urol Suppl 13:e1001","journal-title":"Eur Urol Suppl"},{"issue":"4","key":"1856_CR38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.eururo.2006.10.037","volume":"51","author":"GT MacLennan","year":"2007","unstructured":"MacLennan GT, Kirkali Z, Cheng L (2007) Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol 51(4):889\u2013897 (discussion 897-8)","journal-title":"Eur Urol"},{"issue":"4","key":"1856_CR39","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.eururo.2012.08.025","volume":"63","author":"M Rink","year":"2013","unstructured":"Rink M, Furberg H, Zabor EC, Xylinas E, Babjuk M, Pycha A, Lotan Y, Karakiewicz PI, Novara G, Robinson BD, Montorsi F, Chun FK, Scherr DS, Shariat SF (2013) Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol 63(4):724\u2013732","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1856-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-016-1856-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1856-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-016-1856-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T11:43:44Z","timestamp":1568029424000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-016-1856-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s00345-016-1856-9","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]}}}